KCG News Alert Kcg Holdings Inc (KCG) 12.64 02/14/2015 19:19

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Kcg Holdings Inc (KCG) 12.64 $KCG

KCG RELEASES JANUARY 2015 TRADE VOLUMES
Thomson Reuters ONE - Fri Feb 13, 6:30AM CST
KCG RELEASES JANUARY 2015 TRADE VOLUMES
KCG: 12.64 (-0.08)

GEODESIC NETWORKS, LLC, A SUBSIDIARY OF KCG HOLDINGS, INC., FORMS JOINT VENTURE WITH WORLD CLASS WIRELESS
Thomson Reuters ONE - Thu Feb 12, 7:05AM CST
GEODESIC NETWORKS, LLC, A SUBSIDIARY OF KCG HOLDINGS, INC., FORMS JOINT VENTURE WITH WORLD CLASS WIRELESS
KCG: 12.64 (-0.08)

KCG BONDPOINT EXPANDS INSTITUTIONAL OFFERING
Thomson Reuters ONE - Thu Feb 05, 7:00AM CST

KCG: 12.64 (-0.08)

KCG Holdings' (KCG) CEO Daniel Coleman on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Jan 30, 11:45AM CST

KCG: 12.64 (-0.08)

KCG Holdings (KCG) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Fri Jan 30, 7:55AM CST

KCG: 12.64 (-0.08)

KCG posts 4Q profit
Automated Insights - Fri Jan 30, 6:43AM CST
JERSEY CITY, N.J. (AP) _ KCG Holdings Inc. (KCG) on Friday reported fourth-quarter net income of $26.1 million, after reporting a loss in the same period a year earlier.
KCG: 12.64 (-0.08)

KCG Holdings EPS of $0.23
Seeking Alpha - at Seeking Alpha - Fri Jan 30, 6:07AM CST

KCG: 12.64 (-0.08)

KCG Announces Consolidated Earnings of $0.23 Per Diluted Share for the Fourth Quarter of 2014
PR Newswire - Fri Jan 30, 6:00AM CST
KCG Holdings, Inc. (NYSE: KCG) today reported consolidated earnings of $26.1 million, or $0.23 per diluted share, for the fourth quarter of 2014.
KCG: 12.64 (-0.08)

Notable earnings before Friday’s open
Seeking Alpha - at Seeking Alpha - Thu Jan 29, 4:30PM CST

CNX: 33.60 (+0.87), GHM: 22.84 (+0.04), SPG: 193.11 (-1.61), PCAR: 64.22 (+0.98), NS: 61.94 (-0.06), LM: 57.84 (-0.25), BZH: 17.13 (-0.04), NWL: 39.57 (+0.32), MAT: 27.61 (+0.17), MOG.A: 74.61 (+1.47), WY: 35.52 (-0.04), AVY: 53.79 (+0.14), ABBV: 58.05 (+1.00), HMC: 32.87 (+0.14), MA: 87.14 (-0.38), BERY: 34.98 (+0.03), KCG: 12.64 (-0.08), TYC: 43.19 (+0.27), INGR: 82.82 (+0.59), IMGN: 7.19 (unch), MAN: 77.51 (+0.77), IR: 67.69 (+0.06), XRX: 13.77 (+0.20), LLY: 70.56 (+0.03), TSN: 40.70 (-0.09), MO: 54.76 (-0.78), LEA: 108.70 (-0.73), NVO: 43.76 (+0.61), OFG: 17.19 (-0.31), MOSY: 2.10 (+0.02), IDXX: 159.08 (+1.72), SAIA: 45.59 (+0.98), CVX: 112.78 (+1.92), BEN: 53.91 (+0.23), MGIC: 6.40 (+0.03)

BATS Global to buy KCG Hotspot
Seeking Alpha - at Seeking Alpha - Wed Jan 28, 7:33AM CST

KCG: 12.64 (-0.08)

KCG ANNOUNCES SALE OF KCG HOTSPOT TO BATS GLOBAL MARKETS
Thomson Reuters ONE - Wed Jan 28, 7:15AM CST
KCG ANNOUNCES SALE OF KCG HOTSPOT TO BATS GLOBAL MARKETS
KCG: 12.64 (-0.08), BATS: 15.25 (unch)

Interactive Brokers Beats Q4 Earnings on Lower Expenses - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 21, 8:00AM CST
Interactive Brokers' fourth-quarter 2014 adjusted earnings per share of 12 cents beat the Zacks Consensus Estimate of 5 cents, driven by a decrease in expenses. Also, the figure came in 71% higher than the year-ago quarter earnings of 7 cents.
COWN: 4.76 (+0.06), KCG: 12.64 (-0.08), IBKR: 32.51 (-0.04), ETFC: 25.65 (-0.26)

Schwab Beats Q4 Earnings on Higher Revenues, Expenses Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 16, 11:40AM CST
Schwab's fourth-quarter earnings of 25 cents per share beat the Zacks Consensus Estimate by a penny driven by revenue growth. Further, this was up 9% from 23 cents earned in the year-ago quarter.
KCG: 12.64 (-0.08), IBKR: 32.51 (-0.04), ETFC: 25.65 (-0.26), SCHW: 29.13 (-0.83)

KCG RELEASES DECEMBER 2014 TRADE VOLUMES
Thomson Reuters ONE - Thu Jan 15, 6:30AM CST
KCG RELEASES DECEMBER 2014 TRADE VOLUMES
KCG: 12.64 (-0.08)

KCG Holdings (KCG) Highlighted As Strong And Under The Radar Stock Of The Day
at The Street - Tue Jan 13, 8:45AM CST
Trade-Ideas LLC identified KCG Holdings (KCG) as a strong and under the radar candidate
KCG: 12.64 (-0.08)

KCG Holdings names new CFO
Seeking Alpha - at Seeking Alpha - Tue Jan 06, 7:44AM CST

KCG: 12.64 (-0.08)

KCG APPOINTS STEFFEN PARRATT AS CHIEF FINANCIAL OFFICER
Thomson Reuters ONE - Tue Jan 06, 7:30AM CST
KCG APPOINTS STEFFEN PARRATT AS CHIEF FINANCIAL OFFICER
KCG: 12.64 (-0.08)

GAIN Capital Up to Strong Buy on Improved Trading Metrics - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jan 05, 9:10AM CST
On Jan 3, Zacks Investment Research upgraded GAIN Capital Holdings, Inc. (GCAP) to a Zacks Rank #1 (Strong Buy).
KCG: 12.64 (-0.08), JMP: 7.73 (+0.29), FXCM: 2.21 (-0.01), GCAP: 8.67 (+0.17)

Raymond James Boosts Shareholder Value: Time to Invest? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 02, 10:10AM CST
Raymond James remains focused on boosting its shareholders' return. However, mounting operating expenses make us apprehensive on the stock.
KCG: 12.64 (-0.08), JMP: 7.73 (+0.29), RJF: 57.05 (-0.36), MC: 30.79 (+0.52)

KCG ANNOUNCES FOURTH QUARTER 2014 EARNINGS DATE
Thomson Reuters ONE - Fri Jan 02, 6:30AM CST
KCG ANNOUNCES FOURTH QUARTER 2014 EARNINGS DATE
KCG: 12.64 (-0.08)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

TechCrunch Disrupt 2026: NYSE and Snowflake Highlights

Updated Category News Views 21

Ever noticed how the air vibrates just a bit more when major players like NYSE and Snowflake start shaking hands at big-league events like TechCrunch Disrupt? You'd better believe we're seeing a fresh brew of opportunities and challenges in the market as these titans lock horns and share insights. It's no small feat when the financial nerve center partners into the tech...

Continue Reading
Paradigm Therapeutics: A Beacon in Rare Diseases

Updated Category News Views 4

A Step Towards Recognition You know the old saying: innovation never sleeps. Well, Paradigm Therapeutics seems to have taken that to heart. The company's embarked on a peculiar yet promising journey with SD-101 (Zorblesia™), and here they are, basking in the glow of another nomination for the 2026 Prix Galien USA "Best Start-Up" award. It’s their second shot at this...

Continue Reading
Partner Valuation Advisors Bolsters Team with Eichman

Updated Category News Views 7

Eichman Joins Partner Valuation Advisors as MD Turns out the buzz in real estate appraisal isn’t just about property values these days; it's about who's valuing them. Just ask Partner Valuation Advisors, who are realigning their chess pieces by bringing seasoned pro Justin Eichman, MAI, on board as Managing Director. Talk about playing your cards right. A Heavyweight in...

Continue Reading
Skiptown Expands in Georgia Amid Growing Demand

Updated Category News Views 24

With the pet care industry barking up a storm lately, Skiptown is ramping up efforts to expand its presence in Georgia. The tech-enabled dog care franchise already has a paw print in Atlanta, but it's sniffing out new opportunities across the state. Now they're on the hunt for franchise owners who can bring this modern approach to more communities. Why Georgia? The Growth...

Continue Reading
Think Tank Pushes for Bold Parkinson's Prevention Plan

Updated Category News Views 25

A New Era for Parkinson's Disease Prevention The Parkinson's Foundation has rolled out its battle plan to take on Parkinson's disease from the ground up, shifting gears from managing symptoms to stopping the illness before it starts. It's about damn time, too. With the disease being the fastest-growing neurodegenerative disorder and impacting 10 million people worldwide,...

Continue Reading
Veterans Transitioning to Real Estate with Scholarships

Updated Category News Views 15

Tapping Military Skills for Civilian Gain Finding a new career after military service is a mountain of a task, but veterans now have a golden ticket into the real estate appraisal world. The Appraisal Institute's Next Mission Scholarship is throwing veterans a $1,000 life preserver to dive into a field where their military-honed skills already shine. The Power of a...

Continue Reading
Special Needs Group Partners with MAST to Enhance Accessibility

Updated Category News Views 22

Accessible Travel Takes the Spotlight Ah, the travel biz—just when you think you’ve got it all figured out, along comes a partnership like this to shake things up. Special Needs Group, the big cheese in mobility and medical equipment rentals, is teaming up with MAST Travel Network. Together, they're rolling out initiatives to make the world a bit more accessible, even...

Continue Reading
Omneky Outshines Competitors in AI Ad Scoring

Updated Category News Views 33

Brewing a better ad with AI isn't just about the model you plug in—it's about the wizardry wrapping around it. Omneky's latest caper in the AI advertising game has snagged the spotlight, pulling a hearty 8.8 taste score on a recent TasteBench comparison. That's not a minor tweak, folks, but a whopping 1.2-point lead over the shadow-chasing curves of the next...

Continue Reading
New Data on SKYRIZI Offers Hope for Crohn's Patients

Updated Category News Views 16

Treating Crohn's: New Hope on the Horizon Folks, let me tell you, the landscape for treating Crohn's disease just got a bit more interesting. AbbVie's Phase 3 AFFIRM study has brought some attention-grabbing data on the table, showcasing the potential of their drug, SKYRIZI® (risankizumab-rzaa). This ain't just another run-of-the-mill study; these results could be a...

Continue Reading
Honeywell Aerospace Faces Legal Turbulence in Fraud Case

Updated Category News Views 7

If you've got your chips on Honeywell Aerospace, Inc. (HONA), buckle up because things are getting choppy. Investors who took a bath on their shares now have the chance to put on their legal gloves and join a securities fraud class action lawsuit against the company. Legal Storm Over Misleading Statements Here's the rub: Between June 29 and September 1, 2026, the folks at...

Continue Reading

Top 5 Most Recently Viewed Articles

Pieridae Energy Limited Reports Strong Q3 2024 Performance

Updated Category News Views 58

Strong Financial and Operational Results from Pieridae Energy CALGARY, Alberta - Pieridae Energy Limited (“Pieridae” or the “Company”) (TSX: PEA) has announced its third quarter 2024 financial and operating results, showcasing an impressive production output and robust financial performance. The company achieved a production rate of 23,116 barrels of oil...

Continue Reading
Atea Pharmaceuticals Showcases Promising HCV Treatment Data

Updated Category News Views 136

Innovation in Hepatitis C Treatment by Atea Pharmaceuticals Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) has made a significant impact in the field of antiviral therapeutics through their ongoing research and development efforts. The company recently presented compelling data at The Liver Meeting 2024, highlighting the promising combination of bemnifosbuvir and ruzasvir for...

Continue Reading
Study Confirms Safety of Combined Eye Drops for Surgery Use

Updated Category News Views 172

Introduction to the Study A five-year pharmacovigilance study has confirmed the excellent safety profile of a fixed-dose combination eye drop developed by NTC. This eye drop combines an anti-inflammatory steroid and a quinolone antibiotic, designed for preventing and treating inflammation, as well as preventing infection after cataract surgery. Study Overview The findings...

Continue Reading
New Concerns Arise for Roblox Amid Allegations of Misreported Metrics

Updated Category News Views 203

Allegations Against Roblox: A Closer Look Roblox Corp (NYSE: RBLX) has recently come under fire after a report from Hindenburg Research highlighted potential discrepancies in its reported user metrics, leading to a notable decline in its stock prices. The gaming platform is being questioned for allegedly overstating its user metrics, including daily active users (DAUs)...

Continue Reading
uniQure N.V. Faces Investigation Amid Securities Fraud Concerns

Updated Category News Views 155

Understanding the uniQure N.V. Investigation Currently, uniQure N.V. is under investigation concerning possible violations of securities laws. This inquiry has raised significant concerns for shareholders and potential investors, driving many to seek assistance in understanding their rights moving forward. The investigation is being led by the DJS Law Group, an...

Continue Reading